Yang, G.; Gao, H.; Luo, C.; Zhao, X.; Luo, Q.; Shi, J.; Wang, F.
Palmitic Acid-Conjugated Radiopharmaceutical for Integrin αvβ3-Targeted Radionuclide Therapy. Pharmaceutics 2022, 14, 1327.
https://doi.org/10.3390/pharmaceutics14071327
AMA Style
Yang G, Gao H, Luo C, Zhao X, Luo Q, Shi J, Wang F.
Palmitic Acid-Conjugated Radiopharmaceutical for Integrin αvβ3-Targeted Radionuclide Therapy. Pharmaceutics. 2022; 14(7):1327.
https://doi.org/10.3390/pharmaceutics14071327
Chicago/Turabian Style
Yang, Guangjie, Hannan Gao, Chuangwei Luo, Xiaoyu Zhao, Qi Luo, Jiyun Shi, and Fan Wang.
2022. "Palmitic Acid-Conjugated Radiopharmaceutical for Integrin αvβ3-Targeted Radionuclide Therapy" Pharmaceutics 14, no. 7: 1327.
https://doi.org/10.3390/pharmaceutics14071327
APA Style
Yang, G., Gao, H., Luo, C., Zhao, X., Luo, Q., Shi, J., & Wang, F.
(2022). Palmitic Acid-Conjugated Radiopharmaceutical for Integrin αvβ3-Targeted Radionuclide Therapy. Pharmaceutics, 14(7), 1327.
https://doi.org/10.3390/pharmaceutics14071327